Bryan Johnson, a 45-year-old software developer from Dallas, Texas, is on a mission to regain the body of a teenager. With an estimated net worth of $400 million, Johnson is investing substantial funds into developing a novel anti-aging process that aims to rejuvenate his organs from the inside out.
His ambitious goal involves transforming all aspects of his body, including his skin, bladder, brain, penis, heart, and rectum, to match that of an 18-year-old. Achieving eternal youth, however, comes at an exorbitant cost. Johnson is spending outrageous sums on cutting-edge medical tests, tailored treatments, expert consultants to design his ideal eating, sleeping, and training regimen, and a team of doctors to guide him through the extreme process.
His rigorous routine involves an hour of daily exercise, with additional high-intensity training three times a week, a precisely calculated vegan diet of 1,977 calories, consistent sleep patterns, and participation in various experimental medical procedures.
In his latest endeavor, Johnson has involved his teenage son, Talmage, as a so-called “blood boy.” This term refers to young and fit donors whose plasma is purchased by wealthy individuals seeking to delay the aging process. They believe that infusing themselves with young plasma can rejuvenate their bodies and extend their healthy lifespan. While plasma transfusions are traditionally used to treat medical conditions such as liver disease, blood clotting deficiencies, and burns, proponents of anti-aging treatments view it as a means to maintain vitality.
Typically, donors receive only a fraction of the exorbitant fees charged for these controversial procedures, provided they meet stringent health and youthfulness criteria. Rather than relying on random donors who undergo extensive testing, Bryan chose to use his own flesh and blood.
In a tri-generational exchange of blood plasma, Talmage has a liter of blood removed and separated into plasma, red and white blood cells, and platelets using a machine. Subsequently, Bryan undergoes the same process while Talmage’s plasma is infused into his veins. Finally, Richard, Bryan’s 70-year-old father, has a liter of blood drawn while Bryan’s plasma is transfused into his veins.
While the FDA has cautioned against using plasma infusions for anti-aging purposes due to a lack of proven clinical benefits, Bryan and others like him remain firm believers in the procedure. Although the effectiveness of this process on Bryan and Richard’s organs remains uncertain, researchers express skepticism and concerns about its safety.
Bryan plans to publish the data results from this procedure in the following months, eagerly hoping to validate his pursuit of eternal youth.
